Constellium director buys shares amid strong Q1 growth despite stock overvaluation concerns

A director at Constellium SE purchased 1,325 shares at $31.13 each, signaling confidence after the company reported a record Q1 2026 with 24% revenue growth to $2.5 billion and net income rising to $196 million. Management raised its financial forecast for 2026, expecting adjusted EBITDA between $900 million and $940 million and free cash flow over $275 million. However, some insiders sold $5.8 million in shares recently, and analysis suggests the stock is significantly overvalued at $32.23 compared to a calculated value of $18.46. The director's purchase contrasts with broader insider selling but reflects optimism about the company's strong performance and future prospects.